Literature DB >> 15530417

Interactions within the ubiquitin pathway of Caenorhabditis elegans.

Michelle Gudgen1, Anantharaman Chandrasekaran, Tyralynn Frazier, Lynn Boyd.   

Abstract

The ubiquitin system is a well-conserved and pervasive process for post-synthetic modification of proteins. Three key components of the pathway are required for ubiquitination to occur: the E1 ubiquitin activating enzyme, the E2 ubiquitin conjugating enzyme, and the E3 ubiquitin ligase. There are several different E2 ubiquitin conjugating enzymes and an even greater number of E3 ubiquitin ligases. Interactions between these two groups are critical for substrate ubiquitination. This study reports a two-hybrid analysis of interactions within the ubiquitin system of Caenorhabditis elegans. Forty-three RING finger proteins (presumed E3 ubiquitin ligases) and 14 predicted E2 ubiquitin conjugating enzymes were included in the screen. A total of 31 E2-E3 interactions were uncovered. In addition, the UBC-13 conjugating enzyme was observed to interact with two different E2s, UEV-1 and UBC-1. The interaction of UBC-1 and UBC-13 was confirmed with in vitro ubiquitination reactions. Using NHL-1 as the E3 in the assays, ubiquitination was observed when both UBC-1 and UBC-13 were present but not with either alone. These data imply that some E2s require dimerization in order to function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530417     DOI: 10.1016/j.bbrc.2004.10.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Stabilization of cell polarity by the C. elegans RING protein PAR-2.

Authors:  Yingsong Hao; Lynn Boyd; Geraldine Seydoux
Journal:  Dev Cell       Date:  2006-02       Impact factor: 12.270

Review 2.  Control of asymmetric cell division in early C. elegans embryogenesis: teaming-up translational repression and protein degradation.

Authors:  Sue-Yun Hwang; Lesilee S Rose
Journal:  BMB Rep       Date:  2010-02       Impact factor: 4.778

3.  Ubiquitin-conjugating enzyme genes in Oesophagostomum dentatum.

Authors:  Pauline A Cottee; Youssef G Abs EL-Osta; Alasdair J Nisbet; Robin B Gasser
Journal:  Parasitol Res       Date:  2006-03-04       Impact factor: 2.289

4.  Characterization of a Moniezia expansa ubiquitin-conjugating enzyme E2 cDNA.

Authors:  Hui Zhang; Wen-juan Zhao; Li-chao Kang; Xin-hua Wang; Xin-wen Bo
Journal:  Mol Biol Rep       Date:  2009-05-26       Impact factor: 2.316

5.  A ubiquitin E2 variant protein acts in axon termination and synaptogenesis in Caenorhabditis elegans.

Authors:  Gloriana Trujillo; Katsunori Nakata; Dong Yan; Ichi N Maruyama; Yishi Jin
Journal:  Genetics       Date:  2010-06-30       Impact factor: 4.562

6.  UEV-1 is an ubiquitin-conjugating enzyme variant that regulates glutamate receptor trafficking in C. elegans neurons.

Authors:  Lawrence B Kramer; Jaegal Shim; Michelle L Previtera; Nora R Isack; Ming-Chih Lee; Bonnie L Firestein; Christopher Rongo
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

7.  Ubiquitination is involved in secondary growth, not initial formation of polyglutamine protein aggregates in C. elegans.

Authors:  Gregory A Skibinski; Lynn Boyd
Journal:  BMC Cell Biol       Date:  2012-04-11       Impact factor: 4.241

8.  DLK-1/p38 MAP Kinase Signaling Controls Cilium Length by Regulating RAB-5 Mediated Endocytosis in Caenorhabditis elegans.

Authors:  Aniek van der Vaart; Suzanne Rademakers; Gert Jansen
Journal:  PLoS Genet       Date:  2015-12-11       Impact factor: 5.917

Review 9.  Novel Tsg101 Binding Partners Regulate Viral L Domain Trafficking.

Authors:  Madeleine Strickland; David Nyenhuis; Susan M Watanabe; Nico Tjandra; Carol A Carter
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

10.  Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation.

Authors:  Rebecca A Howard; Pratima Sharma; Connie Hajjar; Kim A Caldwell; Guy A Caldwell; Rusla du Breuil; Rhonda Moore; Lynn Boyd
Journal:  BMC Cell Biol       Date:  2007-07-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.